The ‘Very, Very Bad Look’ of Remdesivir, the First FDA-Approved COVID-19 Drug
Both the EU and the U.S. approved Gilead Sciences drug remdesivir for use against the coronavirus in October, but the decisions baffled scientists who have closely watched the clinical trials unfold—and who have many questions about remdesivir's worth.